{"id":324,"date":"2011-03-25T15:23:27","date_gmt":"2011-03-25T15:23:27","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=324"},"modified":"2011-03-25T15:23:27","modified_gmt":"2011-03-25T15:23:27","slug":"pg-and-teva-pharmaceutical-industries-announce-consumer-health-care-partnership-see-more-at-httpnews-pg-comblogcompany-strategypg-and-teva-pharmaceutical-industries-announce-consumer-health","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2011\/03\/25\/pg-and-teva-pharmaceutical-industries-announce-consumer-health-care-partnership-see-more-at-httpnews-pg-comblogcompany-strategypg-and-teva-pharmaceutical-industries-announce-consumer-health\/","title":{"rendered":"P&G and Teva Pharma Announce Consumer Health Care Partnership"},"content":{"rendered":"

2011-03-25<\/strong> <\/span><\/p>\n

The Procter & Gamble Company (NYSE: PG) and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) on March 24 announced the signing of a master agreement to create a partnership in consumer health care by bringing together both companies’ existing over-the-counter (OTC) medicines and complementary capabilities to accelerate growth.<\/strong><\/p>\n

“This new business model combines P&G’s strong brand-building, consumer-led innovation and go-to-market capabilities with Teva’s broad geographic reach, its experience in R&D, regulatory and manufacturing and its extensive portfolio of products,” Teva Pharmaceutical informed. (Source: P&G Corporate Newsroom)<\/strong><\/p>\n

\u5b9d\u6d01\u4e0e\u68af\u74e6\u7ec4\u5efaOTC\u836f\u5408\u8d44\u516c\u53f8<\/h3>\n

2011-03-25 \u6765\u6e90\uff1a\u65b0\u6d6a\u8d22\u7ecf \u5927 | \u4e2d | \u5c0f<\/p>\n

\u6838\u5fc3\u63d0\u793a\uff1a\u4e16\u754c\u6700\u5927\u6d88\u8d39\u7528\u54c1\u5236\u9020\u5546\u5b9d\u6d01\u516c\u53f8\u5468\u56db\u5ba3\u5e03\uff0c\u5c06\u4e8e\u4e16\u754c\u6700\u5927\u4eff\u5236\u836f\u5236\u9020\u5546\u4ee5\u8272\u5217\u68af\u74e6\u5236\u836f\u516c\u53f8\u5408\u4f5c\uff0c\u8ba1\u5212\u5c06\u5317\u7f8e\u4ee5\u5916\u7684\u975e\u5904\u65b9\u836f(OTC)\u4e1a\u52a1\u5408\u5e76\u4e3a\u4e00\u5bb6\u5408\u8d44\u516c\u53f8\u3002
\n\u65b0\u6d6a\u8d22\u7ecf\u8baf \u5317\u4eac\u65f6\u95f43\u670824\u65e5\u665a\u95f4\u6d88\u606f,\u4e16\u754c\u6700\u5927\u6d88\u8d39\u7528\u54c1\u5236\u9020\u5546\u5b9d\u6d01\u516c\u53f8(PG)\u5468\u56db\u5ba3\u5e03,\u5c06\u4e8e\u4e16\u754c\u6700\u5927\u4eff\u5236\u836f\u5236\u9020\u5546\u4ee5\u8272\u5217\u68af\u74e6\u5236\u836f\u516c\u53f8(Teva Pharmaceutical)\u5408\u4f5c,\u4ee5\u6269\u5927Vicks\u4e0ePepto-Bismol\u7b49\u975e\u5904\u65b9\u836f\u7269\u54c1\u724c\u7684\u5168\u7403\u89e6\u89d2\u3002<\/p>\n

\u5b9d\u6d01\u4e0e\u68af\u74e6\u8868\u793a,\u53cc\u65b9\u8ba1\u5212\u5c06\u5317\u7f8e\u4ee5\u5916\u7684\u975e\u5904\u65b9\u836f(OTC)\u4e1a\u52a1\u5408\u5e76\u4e3a\u4e00\u5bb6\u5408\u8d44\u516c\u53f8,\u4ece\u800c\u5728\u5fb7\u56fd\u3001\u4fc4\u7f57\u65af\u4e0e\u5df4\u897f\u7b49\u5173\u952e\u5e02\u573a\u5efa\u7acb\u9886\u5bfc\u5730\u4f4d,\u540c\u65f6\u52a0\u5feb\u5728\u65b0\u5174\u5e02\u573a\u7684\u589e\u957f\u3002<\/p>\n

\u6b64\u9879\u4ea4\u6613\u4e0d\u5305\u62ec\u68af\u74e6\u7684\u5904\u65b9\u836f\u4e1a\u52a1,\u800c\u4e8e\u5b9d\u6d01\u65b9\u9762\u5219\u65e9\u5728\u4e24\u5e74\u524d\u5c31\u5df2\u5c06\u5176\u5904\u65b9\u836f\u4e1a\u52a1\u4ee531\u4ebf\u7f8e\u5143\u51fa\u552e\u7ed9\u4e86Warner Chilcott PLC(WCRX)\u3002<\/p>\n

\u5b9d\u6d01\u7684\u975e\u5904\u65b9\u836f\u4ea7\u54c1\u5305\u62ec\u611f\u5192\u836fVicks\u3001\u80c3\u836fPepto-Bismol\u3001\u7ea4\u7ef4\u8d28\u8865\u5145\u54c1Metamucil,\u4ee5\u53ca\u80c3\u707c\u70ed\u836f\u7269Prilosec\u3002<\/p>\n

\u68af\u74e6\u603b\u88c1\u517c\u9996\u5e2d\u6267\u884c\u5b98\u65bd\u6d1b\u83ab-\u4e9a\u5948(Shlomo Yanai)\u8868\u793a,\u6b64\u9879\u4ea4\u6613\u5c06\u6269\u5927\u4e24\u516c\u53f8\u7684\u5730\u7f18\u89e6\u89d2,\u5e76\u5c06\u628a\u68af\u74e6\u7684\u836f\u7269\u7814\u53d1\u7ecf\u9a8c\u4e0e\u5168\u7403\u751f\u4ea7\u4e0e\u5b9d\u6d01\u7684\u54c1\u724c\u5efa\u8bbe\u3001\u8425\u9500\u53ca\u6d88\u8d39\u8005\u77e5\u8bc6\u7ed3\u5408\u8d77\u6765\u3002<\/p>\n

\u4e9a\u5948\u8868\u793a,\u65b0\u7684\u5408\u8d44\u516c\u53f8\u7684\u5e74\u5ea6\u8425\u6536\u5927\u7ea6\u4e3a10\u4ebf\u7f8e\u5143,\u9884\u8ba1\u672a\u6765\u51e0\u5e74\u5c06\u8fbe\u523040\u4ebf\u7f8e\u5143\u3002<\/p>\n

\u68af\u74e6\u5c06\u8d1f\u8d23\u5408\u8d44\u516c\u53f8\u7684\u751f\u4ea7,\u5e76\u5c06\u4e3a\u5b9d\u6d01\u7684\u5317\u7f8e\u975e\u5904\u65b9\u836f\u4e1a\u52a1\u4f9b\u5e94\u4ea7\u54c1\u3002\u4e24\u516c\u53f8\u8fd8\u8868\u793a,\u5e0c\u671b\u5f00\u53d1\u65b0\u7684\u975e\u5904\u65b9\u836f\u54c1\u724c,\u5e76\u4e89\u53d6\u8ba9\u66f4\u591a\u7684\u836f\u7269\u53d6\u5f97\u975e\u5904\u65b9\u836f\u5730\u4f4d\u3002<\/p>\n

\u5b9d\u6d01\u53d1\u8a00\u4eba\u6c64\u59c6-\u7c73\u5229\u91d1(Tom Millikin)\u8868\u793a,\u4ea4\u6613\u5b8c\u6210\u540e,\u5b9d\u6d01\u5728\u4e9a\u5229\u6851\u90a3\u5dde\u51e4\u51f0\u57ce\u4ee5\u53ca\u5317\u5361\u7f57\u6765\u7eb3\u5ddeGreensboro\u5de5\u5382\u7684\u5927\u7ea6300\u540d\u5458\u5de5\u5c06\u52a0\u5165\u68af\u74e6\u3002\u5b9d\u6d01\u7684\u975e\u5904\u65b9\u836f\u4e1a\u52a1\u5927\u90e8\u5206\u5728\u5317\u7f8e,\u4f46\u5728\u5357\u975e\u3001\u5370\u5ea6\u4e0e\u5370\u5c3c\u7b49\u6d77\u5916\u5e02\u573a\u4e5f\u62e5\u6709\u4e1a\u52a1\u3002<\/p>\n

\u4e24\u516c\u53f8\u8868\u793a,\u6b64\u9879\u4ea4\u6613\u7684\u7ec6\u8282\u5c1a\u5f85\u843d\u5b9e,\u4e00\u65e6\u843d\u5b9e\u5e76\u83b7\u5f97\u76d1\u7ba1\u6279\u51c6\u540e,\u9884\u8ba1\u4ea4\u6613\u5c06\u4e8e\u4eca\u5e74\u79cb\u5929\u5b8c\u6210\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

2011-03-25 The Procter & Gamble Company (NYSE: PG) and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) on March 24 announced the signing of a master agreement to create a partnership in […]<\/p>\n","protected":false},"author":951,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[5],"tags":[7,8],"class_list":["post-324","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-company-news","tag-consolidation","tag-coopetition"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/951"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=324"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/324\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}